Three cabinet nominees ‒ Robert F. Kennedy Jr., Tulsi Gabbard and Kash Patel ‒ faced a questions from Senate confirmation hearings Thursday.

In a series of aggressive, rapid-fire questions to Robert F. Kennedy Jr. about his plans to replace career scientists at the Maryland-based National Institutes for Health and reform the country’s biggest health agency at large,

Here’s what to know about ultra-processed foods, and how Kennedy has said he plans to shape the U.S. food system.

Sen. Bill Cassidy of Louisiana has emerged as a central figure in the confirmation of Robert F. Kennedy Jr., President Donald Trump's nominee for health and human services secretary.

Robert F. Kennedy Jr.’s nomination to be the nation’s top health official is uncertain after a key Republican joined Democrats to raise persistent concerns over the nominee’s deep skepticism of routine childhood vaccinations that prevent deadly diseases.

For Sen. Maggie Hassan, the falsehoods that have been spread about any link between vaccines and autism are beyond the pale—and hit close to home. The Democratic senator from New Hampshire on Thursday confronted one of the most influential disseminators of this conspiracy theory,

Michael Kosta could not believe this moment from the man President Donald Trump wants in charge of Health and Human Services.

R obert F. Kennedy Jr., President Trump’s pick to head the U.S. Department of Health and Human Services (HHS), was grilled by Democratic senators during his confirmation hearing on Jan. 29 and Jan. 30, who confronted him with conspiratorial and conflicting statements he has made about COVID-19.

We agree that direct-to-consumer prescription-drug advertisements need to be reformed.

Sen. Bill Cassidy, the chairman of the Senate Committee on Health, Education, Labor and Pensions, explains why he is concerned about Robert F. Kennedy Jr. becoming the next secretary of Health and Human Services.

That almost messianic obsession — which arrogantly defies the weight of decades of science supporting the benefits of vaccines — should be enough to sink Kennedy’s nomination. But if they need more, senators should also be troubled by the nominee’s longstanding financial stake in suing the pharmaceutical companies that produce those vaccines.